112 related articles for article (PubMed ID: 12594656)
21. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
Nakanaga K; Saito H; Ishii N; Goto M
Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
[TBL] [Abstract][Full Text] [Related]
22. [Contribution of gene amplification in Mycobacterium ulcerans detection in exudates and cutaneous biopsies in Côte d'Ivoire].
Ekaza E; Kacou-N'Douba A; Oniangué NC; Ehuie P; N'guessan KR; Aka N; Bouzid SA; Faye-Ketté H; Dosso M
Bull Soc Pathol Exot; 2004 May; 97(2):95-6. PubMed ID: 15255348
[TBL] [Abstract][Full Text] [Related]
23. What does detection of Mycobacterium ulcerans DNA in the margin of an excised Buruli ulcer lesion tell us?
Rondini S; Mensah-Quainoo E; Junghanss T; Pluschke G
J Clin Microbiol; 2006 Nov; 44(11):4273-5. PubMed ID: 16928966
[TBL] [Abstract][Full Text] [Related]
24. Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry.
Mwanatambwe M; Yajima M; Etuaful S; Fukunishi Y; Suzuki K; Asiedu K; Yamada N; Asanao G
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):201-5. PubMed ID: 12483968
[TBL] [Abstract][Full Text] [Related]
25. Buruli ulcer.
Moyano LM; Chero JC; Gonzalvez GE;
Am J Trop Med Hyg; 2008 Jul; 79(1):3. PubMed ID: 18606755
[No Abstract] [Full Text] [Related]
26. Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens.
Yeboah-Manu D; Bodmer T; Mensah-Quainoo E; Owusu S; Ofori-Adjei D; Pluschke G
J Clin Microbiol; 2004 Dec; 42(12):5875-6. PubMed ID: 15583329
[TBL] [Abstract][Full Text] [Related]
27. Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana.
Aiga H; Amano T; Cairncross S; Adomako J; Nanas OK; Coleman S
Am J Trop Med Hyg; 2004 Oct; 71(4):387-92. PubMed ID: 15516631
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity.
Debacker M; Aguiar J; Steunou C; Zinsou C; Meyers WM; Scott JT; Dramaix M; Portaels F
Trop Med Int Health; 2004 Dec; 9(12):1297-304. PubMed ID: 15598261
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium ulcerans infections in two horses in south-eastern Australia.
van Zyl A; Daniel J; Wayne J; McCowan C; Malik R; Jelfs P; Lavender CJ; Fyfe JA
Aust Vet J; 2010 Mar; 88(3):101-6. PubMed ID: 20402694
[TBL] [Abstract][Full Text] [Related]
30. Reliability and validity of the Buruli ulcer functional limitation score questionnaire.
Stienstra Y; Dijkstra PU; Van Wezel MJ; Van Roest MH; Beets M; Zijlstra I; Johnson RC; Ampadu EO; Gbovi J; Zinsou C; Etuaful S; Klutse EY; Van der Graaf WT; Van der Werf TS
Am J Trop Med Hyg; 2005 Apr; 72(4):449-52. PubMed ID: 15827284
[TBL] [Abstract][Full Text] [Related]
31. WHO joins battle against a new emerging disease, Buruli ulcer.
Indian Pediatr; 1998 Jun; 35(6):581. PubMed ID: 10216666
[No Abstract] [Full Text] [Related]
32. [Diagnostic image (325). A traveller with a chronic wound].
Goldschmidt WF; Faber WR
Ned Tijdschr Geneeskd; 2007 May; 151(21):1173. PubMed ID: 17557756
[TBL] [Abstract][Full Text] [Related]
33. Prospects for vaccine development against Buruli disease.
Huygen K
Expert Rev Vaccines; 2003 Aug; 2(4):561-9. PubMed ID: 14711340
[TBL] [Abstract][Full Text] [Related]
34. Identification of a new variable number tandem repeat locus in Mycobacterium ulcerans for potential strain discrimination among African isolates.
Ablordey A; Fonteyne PA; Stragier P; Vandamme P; Portaels F
Clin Microbiol Infect; 2007 Jul; 13(7):734-6. PubMed ID: 17403131
[TBL] [Abstract][Full Text] [Related]
35. [Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin].
Johnson RC; Sopoh GE; Boko M; Zinsou C; Gbovi J; Makoutode M; Portaels F
Trop Med Int Health; 2005 Sep; 10(9):863-71. PubMed ID: 16135193
[TBL] [Abstract][Full Text] [Related]
36. [Knowledge-attitudes-practices survey of the Songololo population (D.R. Congo) about Buruli ulcers].
Kibadi Kapay A
Bull Soc Pathol Exot; 2004 Nov; 97(4):302-5. PubMed ID: 17304757
[TBL] [Abstract][Full Text] [Related]
37. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
[TBL] [Abstract][Full Text] [Related]
38. [Buruli ulcer. A case report].
Merone A; Saggiomo G; Severino G; Capone D; De Vincentiis G
Minerva Pediatr; 2001 Dec; 53(6):587-90. PubMed ID: 11740442
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of VNTR typing for the identification of Mycobacterium ulcerans in environmental samples from Victoria, Australia.
Lavender CJ; Stinear TP; Johnson PD; Azuolas J; Benbow ME; Wallace JR; Fyfe JA
FEMS Microbiol Lett; 2008 Oct; 287(2):250-5. PubMed ID: 18754785
[TBL] [Abstract][Full Text] [Related]
40. Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans.
Gooding TM; Kemp AS; Robins-Browne RM; Smith M; Johnson PD
Clin Infect Dis; 2003 Apr; 36(8):1076-7. PubMed ID: 12684923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
